Mathias Mueller
Overview
Explore the profile of Mathias Mueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neuweiler F, Mueller M, Walter B, Landing E, Beranoaguirre A, Sendino C, et al.
Sci Rep
. 2024 Dec;
14(1):31537.
PMID: 39733218
The earliest named stromatolite Cryptozoon Hall, 1884 (Late Cambrian, ca. 490 Ma, eastern New York State), was recently re-interpreted as an interlayered microbial mat and non-spiculate (keratosan) sponge deposit. This...
2.
Woess K, Macho-Maschler S, Schenau D, Butler M, Lassnig C, Valcanover D, et al.
Haematologica
. 2022 Jan;
108(4):993-1005.
PMID: 35021603
Tyrosine kinase 2 (TYK2) is a member of the Janus kinase/signal transducer and activator of transcription pathway, which is central in cytokine signaling. Previously, germline TYK2 mutations have been described...
3.
Pezoldt J, Wiechers C, Erhard F, Rand U, Bulat T, Beckstette M, et al.
Commun Biol
. 2021 Dec;
4(1):1355.
PMID: 34857864
Our understanding of the composition and functions of splenic stromal cells remains incomplete. Here, based on analysis of over 20,000 single cell transcriptomes of splenic fibroblasts, we characterized the phenotypic...
4.
Thannesberger J, Edermayr A, Karimi A, Mueller M, Karnthaler U, Gauss R, et al.
Viruses
. 2021 Oct;
13(10).
PMID: 34696444
Currently countries across the globe are preparing for the fourth wave of SARS-CoV-2 infections, which is mainly driven by the rapid spread of novel SARS-CoV-2 variants. Austria and, in particular,...
5.
Jaggi U, Matundan H, Yu J, Hirose S, Mueller M, Wormley Jr F, et al.
PLoS Pathog
. 2021 Oct;
17(10):e1009999.
PMID: 34653236
Ocular HSV-1 infection is a major cause of eye disease and innate and adaptive immunity both play a role in protection and pathology associated with ocular infection. Previously we have...
6.
Poelzl A, Lassnig C, Tangermann S, Hromadova D, Reichart U, Gawish R, et al.
Cell Death Differ
. 2020 Sep;
28(2):748-763.
PMID: 32929218
The non-canonical inflammasome is an emerging crucial player in the development of inflammatory and neurodegenerative diseases. It is activated by direct sensing of cytosolic lipopolysaccharide (LPS) by caspase-11 (CASP11), which...
7.
Roewe J, Stavrides G, Strueve M, Sharma A, Marini F, Mann A, et al.
Nat Commun
. 2020 Aug;
11(1):4035.
PMID: 32788578
Polyphosphates are linear polymers and ubiquitous metabolites. Bacterial polyphosphates are long chains of hundreds of phosphate units. Here, we report that mouse survival of peritoneal Escherichia coli sepsis is compromised...
8.
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia
Kollmann S, Grundschober E, Maurer B, Warsch W, Grausenburger R, Edlinger L, et al.
Leukemia
. 2019 Jan;
33(7):1583-1597.
PMID: 30679796
Deregulation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway is found in cancer with STAT5A/B controlling leukemic cell survival and disease progression. As mutations in STAT5B,...
9.
Porpaczy E, Tripolt S, Hoelbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, et al.
Blood
. 2018 Jun;
132(7):694-706.
PMID: 29907599
Inhibition of Janus-kinase 1/2 (JAK1/2) is a mainstay to treat myeloproliferative neoplasms (MPN). Sporadic observations reported the co-incidence of B-cell non-Hodgkin lymphomas during treatment of MPN with JAK1/2 inhibitors. We...
10.
van Drunen W, Mueller M, Glukhovskoy A, Salcher R, Wurz M, Lenarz T, et al.
Biomed Res Int
. 2017 Dec;
2017:6369247.
PMID: 29214174
Introduction: Most implantable hearing aids currently available were developed to compensate the sensorineural hearing loss by driving middle ear structures (e.g., the ossicles). These devices are successfully used in round...